Understanding Your Diagnosis: Membranous Nephropathy
At a Glance
Membranous nephropathy is an autoimmune kidney disease that makes the kidney filters leak protein, causing nephrotic syndrome and swelling. Risk depends on protein loss and kidney function; some people go into remission, while others need medicines such as rituximab.
Getting a diagnosis of membranous nephropathy (MN) can feel overwhelming, especially because it is quite rare. In adults, only about 8 to 12 people out of every million are diagnosed with the primary form of this disease each year [1][2]. Because it isn’t common, you may find that your primary care doctor or local clinic has limited experience managing it. This is a specialized condition, and your feelings of uncertainty are a normal response to navigating a rare diagnosis.
What is Membranous Nephropathy?
In simple terms, MN is an autoimmune disease where your immune system mistakenly attacks the filters in your kidneys. Your kidneys contain millions of tiny filtering units called glomeruli. Inside these filters are specialized cells called podocytes that act like a fine mesh screen to keep important proteins in your blood while letting waste pass through into your urine [3].
In MN, your body produces autoantibodies (proteins that attack your own tissues) that stick to these podocytes. This creates a “clumping” effect called immune deposits [4][5]. These clumps damage the mesh screen, causing it to leak. The most common target of this attack is a protein called PLA2R, which is found in about 70% to 80% of cases [4].
Understanding Nephrotic Syndrome
The result of this “leaky filter” is a condition called nephrotic syndrome. While the name sounds complicated, it describes a specific set of symptoms that happen when your kidneys lose too much protein [6]:
- Proteinuria: Large amounts of protein (mainly albumin) leak into your urine.
- Hypoalbuminemia: Because so much protein is being lost in the urine, the level of albumin in your blood drops significantly.
- Edema: Albumin’s job is to keep fluid inside your blood vessels. When albumin levels drop, fluid leaks out into your tissues, causing swelling in your legs, ankles, and sometimes your face or abdomen.
- High Cholesterol: Your liver tries to compensate for the lost protein by working harder, which accidentally causes it to produce extra cholesterol.
Knowing the Red Flags
While MN usually moves slowly, the protein loss makes your blood “thicker” and more prone to clotting. It is essential to distinguish between the typical, gradual swelling of MN and true medical emergencies.
Seek emergency care immediately if you experience:
- Blood Clots (Thromboembolism): This is the most serious risk. A clot in the leg (Deep Vein Thrombosis or DVT) usually causes swelling, pain, or redness in only one leg [7]. If a clot travels to the lungs (Pulmonary Embolism or PE), it can cause sudden shortness of breath, sharp chest pain when breathing, or coughing up blood [8][9].
- Renal Vein Thrombosis: A clot can also form in the vein leaving the kidney. This may cause sudden, severe pain in your side or back (flank pain) and blood in your urine [10].
- Acute Fluid Overload: If your swelling worsens very rapidly and you find it hard to breathe even while resting or lying flat, your body may be overwhelmed by fluid [11][12].
- Kidney Failure: A sudden, sharp drop in the amount of urine you produce can signal that the kidneys are struggling to function [12].
- Fever or Infection: If you are taking immune-suppressing medications, a fever can be a medical emergency. Ask your doctor for a clear plan on who to call if a fever develops.
The “Rule of Thirds” and Your Outlook
MN is often a “wait and see” disease because it frequently resolves on its own. Doctors historically refer to the Rule of Thirds to describe the typical path of the disease [13]:
- One-third of patients experience spontaneous remission, meaning the protein leak stops on its own without aggressive immune-suppressing drugs [14][15].
- One-third stay stable. They may continue to have some protein in their urine but their kidney function remains steady for a long time.
- One-third will see their kidney function slowly decline over years, eventually needing more intensive treatment or dialysis [13].
This is a historical rule based on older populations, not a personal prediction. While lower-risk patients may undergo a period of observation (often 6 months) while using blood pressure medications to protect the kidneys before starting stronger treatments [4][16], this is not automatic. If you have severe symptoms, your care team may act earlier. Modern treatments, including newer “biologic” medications like rituximab, have improved these odds, with many patients achieving remission through medical care [17][18]. Your journey with MN is a marathon, not a sprint, and your care team will monitor your blood and urine levels closely to decide the best time to act.
Common questions in this guide
What happens in membranous nephropathy?
What symptoms can membranous nephropathy cause?
Which symptoms mean I should seek emergency care?
Does membranous nephropathy always require immune-suppressing treatment?
What does the rule of thirds mean for membranous nephropathy?
How do doctors assess my risk and decide when to treat?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on membranous glomerulonephritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current risk category based on my protein levels and kidney function?
- 2.What was my anti-PLA2R antibody level at diagnosis, and how often will we retest it?
- 3.Based on my albumin levels, do I need a blood thinner to prevent clots?
- 4.Is my condition 'primary' or 'secondary,' and what tests were used to confirm that?
- 5.Given the historical 'rule of thirds,' how long should we wait for spontaneous remission before starting immunosuppression?
- 6.What specific 'Red Flag' symptoms should I call you about immediately versus going to the ER?
References
References (18)
- 1
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop.
Prunotto M, Nachman PH, Gillespie BS, et al.
Kidney international 2025; (107(5)):809-815 doi:10.1016/j.kint.2024.09.020.
PMID: 40088237 - 2
Primary membranous nephropathy: comprehensive review and historical perspective.
Keri KC, Blumenthal S, Kulkarni V, et al.
Postgraduate medical journal 2019; (95(1119)):23-31 doi:10.1136/postgradmedj-2018-135729.
PMID: 30683678 - 3
Membranous nephropathy.
Dantas M, Silva LBB, Pontes BTM, et al.
Jornal brasileiro de nefrologia 2023; (45(2)):229-243 doi:10.1590/2175-8239-JBN-2023-0046en.
PMID: 37527529 - 4
Membranous Nephropathy: Updates on Management.
Bharati J, Waguespack DR, Beck LH
Advances in kidney disease and health 2024; (31(4)):299-308 doi:10.1053/j.akdh.2024.04.004.
PMID: 39084755 - 5
Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.
Chung EYM, Wang YM, Keung K, et al.
Frontiers in immunology 2022; (13()):1036249 doi:10.3389/fimmu.2022.1036249.
PMID: 36405681 - 6
Membranous nephropathy: new pathogenic mechanisms and their clinical implications.
Hoxha E, Reinhard L, Stahl RAK
Nature reviews. Nephrology 2022; (18(7)):466-478 doi:10.1038/s41581-022-00564-1.
PMID: 35484394 - 7
A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.
Zou PM, Li H, Cai JF, et al.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2018; (33(2)):91-99 doi:10.24920/11809.
PMID: 29976278 - 8
Treatment of very high risk membranous nephropathy complicated by pulmonary embolism with glucocorticoids and rituximab: Case report.
Khan UF, Sia C, Thamboo TP, et al.
Medicine 2025; (104(2)):e41241 doi:10.1097/MD.0000000000041241.
PMID: 39792734 - 9
Bilateral Pulmonary Embolism in a 12-Year-Old Girl with Steroid-Resistant Nephrotic Syndrome.
Safdar OY, Rajab RH, Alghanemi RG, et al.
Children (Basel, Switzerland) 2020; (7(6)) doi:10.3390/children7060062.
PMID: 32549197 - 10
Renal Vein Thrombosis: A Narrative Review.
Riva N, Gatt A, Gauci MA, et al.
Diagnostics (Basel, Switzerland) 2026; (16(12)) doi:10.3390/diagnostics16121805.
PMID: 42351464 - 11
Revealing the Intersection: Scleroderma Renal Crisis Complicating Membranous Nephropathy.
Kazi AU, Kibria SM, Rahman Shipi M, et al.
Cureus 2025; (17(5)):e83327 doi:10.7759/cureus.83327.
PMID: 40458351 - 12
Extracapillary Proliferation Superimposed on Primary Membranous Glomerulonephritis: A Case Report.
El Kaoua O, Hamouche N, Chettati M, et al.
Cureus 2026; (18(2)):e103903 doi:10.7759/cureus.103903.
PMID: 41869110 - 13
[Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B, Lambeau G, Esnault V
Nephrologie & therapeutique 2017; (13 Suppl 1()):S75-S81 doi:10.1016/j.nephro.2017.01.012.
PMID: 28577747 - 14
Primary Membranous Nephropathy.
Couser WG
Clinical journal of the American Society of Nephrology : CJASN 2017; (12(6)):983-997 doi:10.2215/CJN.11761116.
PMID: 28550082 - 15
A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
Storrar J, Gill-Taylor T, Chinnadurai R, et al.
PloS one 2022; (17(10)):e0276053 doi:10.1371/journal.pone.0276053.
PMID: 36228014 - 16
How to Choose the Right Treatment for Membranous Nephropathy.
Peritore L, Labbozzetta V, Maressa V, et al.
Medicina (Kaunas, Lithuania) 2023; (59(11)) doi:10.3390/medicina59111997.
PMID: 38004046 - 17
Ten tips on immunosuppression in primary membranous nephropathy.
Trujillo H, Caravaca-Fontán F, Praga M
Clinical kidney journal 2024; (17(6)):sfae129 doi:10.1093/ckj/sfae129.
PMID: 38915435 - 18
Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
Albertazzi V, Fontana F, Giberti S, et al.
Journal of nephrology 2024; (37(2)):471-482 doi:10.1007/s40620-023-01803-9.
PMID: 37957455
This page is for informational purposes only and does not constitute medical advice about membranous nephropathy. Follow your nephrology team’s guidance for interpreting results, choosing treatment, and responding to emergency symptoms.